Evaluation of the efficacy and tolerability of naftidrofuryl in the therapy of chronic cerebral ischemia
Objective: to study the clinical efficacy and tolerability of naftidrofuryl (Duzofarm®) in patients with chronic cerebral ischemia (CCI).Patients and methods. A prospective open-label multicenter observational study evaluated the clinical efficiency and tolerability of naftidrofuryl treatment in pat...
Main Authors: | M. N. Dadasheva, I. A. Zolotovskaya, R. V. Gorenkov, K. N. Dadasheva, D. I. Lebedeva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2021-02-01
|
Series: | Неврология, нейропсихиатрия, психосоматика |
Subjects: | |
Online Access: | https://nnp.ima-press.net/nnp/article/view/1505 |
Similar Items
-
Possibilities nootropic drugs in non-demented patients with vascular cognitive disorders
by: M. N. Dadasheva, et al.
Published: (2022-04-01) -
NAFTIDROFURYL USE IN MODERATE VASCULAR COGNITIVE DISORDERS
by: V. A. Parfenov, et al.
Published: (2017-12-01) -
Modern aspects of diagnosis and treatment of chronic cerebral ischemia. Application of naftidrofuryl
by: V. A. Parfyonov
Published: (2015-12-01) -
The efficacy and safety of ethyl methyl hydroxypyridine succinate used as part of sequential therapy in patients with chronic cerebral ischemia
by: V. V. Burdakov, et al.
Published: (2020-02-01) -
Possibilities of using naftidrofuryl in the therapy of cerebrovascular diseases: Literature review and the authors’ observations
by: A. N. Belova, et al.
Published: (2016-01-01)